Apeloa Pharmaceutical Co.,Ltd

XSEC:000739 Stock Report

Market Cap: CN¥18.6b

Apeloa PharmaceuticalLtd Management

Management criteria checks 4/4

Apeloa PharmaceuticalLtd's CEO is Chun He, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.004% of the company’s shares, worth CN¥703.69K. The average tenure of the management team and the board of directors is 11.8 years and 5.8 years respectively.

Key information

Chun He

Chief executive officer

CN¥903.6k

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.004%
Management average tenure11.8yrs
Board average tenure5.8yrs

Recent management updates

Recent updates


CEO

Chun He (50 yo)

less than a year

Tenure

CN¥903,600

Compensation

Mr. Chun He is General Manager of Apeloa Pharmaceutical Co. Ltd. since 2024 and served as its Senior Deputy General Manager until 2024 and served as its GM of Formulation Division since June 2022 until 202...


Leadership Team

NamePositionTenureCompensationOwnership
Fangmeng Zhu
Chairman11.8yrsCN¥2.40m0.019%
CN¥ 3.6m
Chun He
General Managerless than a yearCN¥903.60k0.0038%
CN¥ 703.7k
Xinliang Xu
Vice Chairmanless than a yearCN¥1.44m0.0095%
CN¥ 1.8m
Jinhui Zhang
Chief Financial Officer5.9yrsCN¥653.60k0.00038%
CN¥ 70.7k
Min Jin
Senior Deputy GM & GM of API Divisionno dataCN¥903.60k0.0043%
CN¥ 804.2k
Lei Cai
Deputy GM & GM of CDMO Divisionno dataCN¥810.00k0.0043%
CN¥ 804.2k
Yuwang Zhou
Deputy GM & Secretaryno dataCN¥633.60kno data
Hui Zhang
Chief Technology Officer13.6yrsCN¥360.00kno data

11.8yrs

Average Tenure

52yo

Average Age

Experienced Management: 000739's management team is seasoned and experienced (11.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Fangmeng Zhu
Chairman11.8yrsCN¥2.40m0.019%
CN¥ 3.6m
Xinliang Xu
Vice Chairmanless than a yearCN¥1.44m0.0095%
CN¥ 1.8m
Xing Wu
Non-Independent Director11.8yrsCN¥2.80m0.0086%
CN¥ 1.6m
Wencai Xu
Non-Independent Director23yrsno datano data
Tiangao Hu
Non-Independent Director16.6yrsno datano data
Xiangquan Ge
Supervisor1.7yrsno datano data
Guoping Li
Chairman of the Supervisory Board7yrsno datano data
Ling Chen
Independent Director4.7yrsCN¥88.20kno data
Juan Ping Qian
Independent Director3.7yrsCN¥88.20kno data
Weiguang Pan
Independent Director2.8yrsCN¥88.20kno data

5.8yrs

Average Tenure

54.5yo

Average Age

Experienced Board: 000739's board of directors are considered experienced (5.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 15:38
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Apeloa Pharmaceutical Co.,Ltd is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jin ZhangChina International Capital Corporation Limited
Wanhua WuChina International Capital Corporation Limited
Shanshan LiChina Merchants Securities Co. Ltd.